Search results
Buckle Bunny: 15 interesting things you should know about Tanner Adell
Revolt· 12 hours agoTanner Adell is a star on the rise, defying outdated beliefs that Black artists don’t belong in the...
DCT Tracker: tracing industry’s adoption of decentralised clinical trials
Clinical Trials Arena· 13 hours agoAcademic centres are on the frontlines of scientific breakthroughs, so it is not surprising they are...
IIT Madras Pravartak registrations for free course on OOBT through Math open
Indian Express· 5 days agoIIT Madras Pravartak Technologies Foundation has opened for registrations for the ‘Out of the Box...
How Atlassian's Team Anywhere is shaping the future of work
YourStory· 18 hours agoAs the Indian workforce grapples with the ongoing debate over the return to office mandates, the...
Lilly joins fellow pharma giants in OpenAI partnership
Pharmaceutical Technology· 5 days agoThe AMR fund has supported other companies like Vedanta Biosciences...WHO), there were 1.27 million...
VenoStent raises $20m in Series A to develop bioabsorbable perivascular wrap
Clinical Trials Arena· 4 days agoWe look forward to working with the VenoStent team as it proves the efficacy of this breakthrough...
IIT-K launches technology to detect Bovine mastitis | - Times of India
The Times of India· 4 days agoKanpur: In a breakthrough discovery aiming to check the economic loss in dairy industries caused by the disease Bovine mastitis, the Indian Institute of Technology Kanpur ...
Stocks to watch: Zydus Lifesciences, Dr Reddy's, Cochin Shipyard, and PTC Industries shares in focus
Firstpost· 1 day agoThe Indian stock market is likely to start the day on a flat note. Asian stocks have given mixed...
Technology Stocks: Riding the wave of innovation in the US market
Financial Express· 5 days agoTechnology companies are a hot topic, especially in the US markets.
VenoStent raises $20m in Series A to develop bioabsorbable perivascular wrap
Medical Device Network· 4 days agoWe look forward to working with the VenoStent team as it proves the efficacy of this breakthrough...